This observation suggests that, in addition to (or instead of) VEGF, multiple other mediators may contribute to vascular growth and remodelling within the vasculature supplying the tumour mass [25] and at metastatic distant organ sites [54], often acting in ways that may not involve canonical pathways of angiogenesis. The gene discussed is VEGFA; the disease is neoplasm.